Searched for
NEULAND LAB
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 26%On Thursday evening, US President Trump said he would “hit Iran hard tonight”. Then, as the world waited with bated breath, came the announ...- Stock picks of the week; 5 stocks with consistent score improvement and upside potential of up to 25%Even in normal times it is futile to try and guess the outcome of most global events. But in the New World Order, it makes no sense at all ...
- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsHas a peace deal been agreed on by the US and Iran? Will the fragile ceasefire hold? No one can answer these questions with any certainty. ...
- Small & midcaps rally! Wockhardt, Coforge, other stocks surge up to 14%. Do you own any?Smallcap and midcap stocks surged on Wednesday, outperforming broader market indices with gains of around 1% each. This rally was fueled by...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat we are witnessing in the market these days is similar to scenarios that have played out in the past. There have been many points in th...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsOver the next few sessions, as the uncertainty caused by the Gulf war intensifies and makes you anxious, remember this: It is not the first...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat is evident in the last few trading sessions is how the street is treating Q4 earnings numbers. If a company delivers in terms of numbe...
- Neuland Labs shares soar 10%, hit 52-week high after Q2 PAT spikes 201% YoYNeuland Laboratories’ shares hit a 52-week high after the company posted stellar Q2FY26 results. PAT surged 201.6% YoY to ₹96.5 crore, reve...
- Sensex rises! These stocks are up over 15% on BSEIn the Nifty50 index, 28 stocks were trading in the green, while 22 stocks were in the red.
- Goldman picks 2 pharma stocks, screams sells on Laurus LabsGoldman Sachs' ratings triggered price movements, with Syngene and Neuland rising but Laurus falling. Syngene is set to benefit from China+...
- Buy Neuland Laboratories, target Rs 1000: HDFC SecuritiesBuy Neuland Laboratories Ltd. at a price target of Rs 1000..
- USFDA inspection was planned and company was informed in advance: Sucheth Rao Davuluri, Neuland LabsIn an exclusive chat with ET Now, Sucheth Rao Davuluri, VC & CEO, Neuland Labs, said that the firm has already started working on clearing ...
- US regulator makes 2 observations at Neuland Labs' facility"The USFDA inspected Unit 1, manufacturing facility at Bonthapally, Hyderabad of the company from April 3-7, 2017. At the end of the inspec...
- Neuland Labs and Aarti Ind our top two buy ideas: Siddhartha KhemkaThe Chinese currency has appreciated about 5 per cent in the last five years compared with the Indian currency, which has depreciated about...
- Evolvence India Fund to exit Neuland Labs; puts entire stake of 33 per cent on saleVishy Chebrol, one of the founders and managing directors of InvAscent, confirmed the fund is looking at exiting its investment in the comp...
- Neuland Labs to focus on contract researchHyderabad-based mid-sized pharma player Neuland Labs has raised $30 million for capital expenditure on contract research facilities and its...
Load More
